Investigating microglia’s role in Alzheimer’s pathology
Unlocking Alzheimer’s Secrets: How Targeting Microglia with TREM2 Agonists Could Revolutionize Treatment Alzheimer’s disease (AD), a devastating neurodegenerative disorder, continues to challenge medical science. Recent research, published in BIO Integration, offers a promising new avenue for treatment: manipulating the activity of microglia, the brain’s resident immune cells, using a TREM2 agonist monoclonal antibody (hT2AB). This … Read more